AntiCancer Inc, San Diego, CA, U.S.A.
Department of Surgery, University of California, San Diego, CA, U.S.A.
In Vivo. 2020 Sep-Oct;34(5):2277-2280. doi: 10.21873/invivo.12038.
BACKGROUND/AIM: Near-infrared (NIR) fluorescence imaging using indocyanine green (ICG) is used to visualize colon-cancer liver metastases (CCLM) during surgery. The present study aimed to use ICG to visualize small CCLM in an orthotopic mouse model.
A 3-mm fragment of HT29 human colon cancer was implanted to the liver of 5 athymic nude mice (nu/nu). The Pearl Trilogy Small Animal Fluorescence Imaging system was used 24 h after intravenous (IV) injection of 0.025 mg (0.25 mg/ml) ICG.
In four of the five mice, tumor fluorescence was detected. Small tumors (approximately 3 mm) were distinctly visualized with a minimal fluorescence liver signal, with a mean tumor to liver signal ratio of 1.81 (SD±0.167).
Small CCLM can be clearly identified by ICG fluorescence in an orthotopic nude-mouse model. This model is translatable to the clinic for the detection of occult early CCLM.
背景/目的:近红外(NIR)荧光成像使用吲哚菁绿(ICG)用于在手术期间可视化结肠癌肝转移(CCLM)。本研究旨在使用 ICG 在原位小鼠模型中可视化小的 CCLM。
将 3mm 片段的 HT29 人结肠癌植入 5 只无胸腺裸鼠(nu/nu)的肝脏中。在静脉内(IV)注射 0.025mg(0.25mg/ml)ICG 后 24 小时使用 Pearl Trilogy 小动物荧光成像系统进行检测。
在五只小鼠中的四只中,检测到肿瘤荧光。通过最小的肝脏荧光信号可以清楚地看到小肿瘤(约 3mm),肿瘤与肝脏信号的平均比值为 1.81(SD±0.167)。
在原位裸鼠模型中,ICG 荧光可清晰识别小的 CCLM。该模型可转化为临床检测隐匿性早期 CCLM。